Page last updated: 2024-08-21

tocopherols and Colonic Neoplasms

tocopherols has been researched along with Colonic Neoplasms in 18 studies

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (44.44)29.6817
2010's9 (50.00)24.3611
2020's1 (5.56)2.80

Authors

AuthorsStudies
Chen, Y; Feng, N; Feng, Y; Li, S; Ouyang, Y; Wu, Q; Zhang, L; Zhao, K1
Chen, A; Guan, F; Ju, J; Li, G; Yang, CS; Yang, Z1
Dolfi, SC; Guan, F; Hong, J; Lee, MJ; Yang, CS; Yang, Z1
Huang, J; Jang, Y; Jiang, Q; Park, NY; Rostgaard-Hansen, AL1
Chen, JX; Chi, E; Lee, MJ; Liu, A; Reuhl, K; Suh, N; Wang, H; Yang, CS; Yu, S1
Gao, P; Li, Z; Xu, Y; Yao, J1
Ju, J; Li, GX; Lu, G; Yang, CS1
Kabat, GC; Kim, MY; Rohan, TE; Sarto, GE; Shikany, JM1
Chen, YK; Guan, F; Lee, MJ; Li, G; Lin, Y; Liu, AB; Shih, W; Yang, CS; Yang, Z1
Brownlow, B; Elbayoumi, T; Jordan, M; Nayel, A1
Barnett, KT; Fokum, FD; Malafa, MP1
Campbell, SE; Krishnan, K; Qui, M; Stone, WL; Whaley, SG1
Clifton, GD; Exon, JH; Fariss, MW; South, EH; Taruscio, TG1
Campbell, SE; Krishnan, K; Qui, M; Stone, WL; Whaley, SG; Yang, H1
Cho, JS; Choi, HG; Choi, MK; Chun, KH; Lee, E; Lee, YJ; Lim, SJ; Park, DH; Park, W1
Coffey, RJ; Gellert, N; Lu, M; Mayne, GC; Nègre-Salvayre, A; Neuzil, J; Olejnicka, B; Ostermann, G; Schröder, A; Stícha, M; Weber, C; Weber, T1
Brunk, UT; Neuzil, J; Terman, A; Weber, C; Weber, T1
Andera, L; Brunk, UT; Coffey, RJ; Erl, W; Fariss, MW; Gellert, N; Korinek, V; Lahm, H; Lu, M; Neuzil, J; Sattler, W; Schröder, A; Terman, A; Ucker, DS; Weber, C; Weber, T1

Reviews

4 review(s) available for tocopherols and Colonic Neoplasms

ArticleYear
Cancer prevention by tocopherols and tea polyphenols.
    Cancer letters, 2013, Jun-28, Volume: 334, Issue:1

    Topics: Animals; Anticarcinogenic Agents; Colonic Neoplasms; Disease Models, Animal; Humans; Lung Neoplasms; Male; Mice; Polyphenols; Prostatic Neoplasms; Tea; Tocopherols; Vitamin E

2013
Inhibition of inflammation and carcinogenesis in the lung and colon by tocopherols.
    Annals of the New York Academy of Sciences, 2010, Volume: 1203

    Topics: Animals; Antineoplastic Agents; Antioxidants; Cell Transformation, Neoplastic; Colonic Neoplasms; Humans; Inflammation Mediators; Lung Neoplasms; Tocopherols

2010
Tocopherols and the treatment of colon cancer.
    Annals of the New York Academy of Sciences, 2004, Volume: 1031

    Topics: alpha-Tocopherol; Animals; Chemoprevention; Colon; Colonic Neoplasms; Diet; gamma-Tocopherol; Gene Expression; Humans; Iron, Dietary; Oxidative Stress; PPAR gamma; Proto-Oncogene Proteins p21(ras); Rats; Tocopherols; Tumor Cells, Cultured

2004
Vitamin E analogues as inducers of apoptosis: implications for their potential antineoplastic role.
    Redox report : communications in free radical research, 2001, Volume: 6, Issue:3

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Cell Cycle; Colonic Neoplasms; Drug Screening Assays, Antitumor; Free Radical Scavengers; Free Radicals; Gene Expression Regulation; Humans; Intestinal Mucosa; Intracellular Membranes; Lysosomes; Macrophages; Mice; Mice, Nude; Mitochondria; Molecular Structure; Neoplastic Stem Cells; Oxidation-Reduction; Protein Kinase C; Reactive Oxygen Species; Signal Transduction; Stem Cells; Tocopherols; Tumor Cells, Cultured; Vitamin E; Xenograft Model Antitumor Assays

2001

Other Studies

14 other study(ies) available for tocopherols and Colonic Neoplasms

ArticleYear
Effect of lotus seedpod oligomeric procyanidins on AGEs formation in simulated gastrointestinal tract and cytotoxicity in Caco-2 cells.
    Food & function, 2021, Apr-26, Volume: 12, Issue:8

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caco-2 Cells; Catechin; Colonic Neoplasms; Digestion; Gastrointestinal Tract; Gene Expression; Glycation End Products, Advanced; Humans; Inflammation; Nelumbo; Pepsin A; Proanthocyanidins; Reactive Oxygen Species; Seeds; Tocopherols; Trypsin Inhibitors

2021
Inhibitory effects of different forms of tocopherols, tocopherol phosphates, and tocopherol quinones on growth of colon cancer cells.
    Journal of agricultural and food chemistry, 2013, Sep-11, Volume: 61, Issue:36

    Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Colonic Neoplasms; HCT116 Cells; HT29 Cells; Humans; Phosphates; Quinones; Tocopherols

2013
Vitamin E metabolite 13'-carboxychromanols inhibit pro-inflammatory enzymes, induce apoptosis and autophagy in human cancer cells by modulating sphingolipids and suppress colon tumor development in mice.
    Free radical biology & medicine, 2016, Volume: 95

    Topics: Animals; Apoptosis; Arachidonate 5-Lipoxygenase; Autophagy; Chromans; Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Garcinia kola; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Mice; Sphingolipids; Tocopherols; Vitamin E

2016
δ- and γ-tocopherols inhibit phIP/DSS-induced colon carcinogenesis by protection against early cellular and DNA damages.
    Molecular carcinogenesis, 2017, Volume: 56, Issue:1

    Topics: Animals; Anticarcinogenic Agents; Carcinogenesis; Colon; Colonic Neoplasms; Cytochrome P-450 CYP1A1; Dextran Sulfate; DNA Damage; gamma-Tocopherol; Humans; Imidazoles; Male; Mice; Oxidative Stress; Tocopherols; Vitamins

2017
α-TEA inhibits the growth and motility of human colon cancer cells via targeting RhoA/ROCK signaling.
    Molecular medicine reports, 2016, Volume: 14, Issue:3

    Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Colonic Neoplasms; Enzyme Activation; Humans; Phosphorylation; rho-Associated Kinases; rhoA GTP-Binding Protein; RNA, Small Interfering; Signal Transduction; Tocopherols

2016
Repeated measurements of serum carotenoid, retinol and tocopherol levels in relation to colorectal cancer risk in the Women's Health Initiative.
    European journal of clinical nutrition, 2012, Volume: 66, Issue:5

    Topics: Aged; Antioxidants; beta Carotene; Carotenoids; Colonic Neoplasms; Colorectal Neoplasms; Female; Humans; Incidence; Middle Aged; Nutrition Assessment; Nutritional Status; Proportional Hazards Models; Risk Factors; Tocopherols; Vitamin A; Women's Health

2012
δ- and γ-tocopherols, but not α-tocopherol, inhibit colon carcinogenesis in azoxymethane-treated F344 rats.
    Cancer prevention research (Philadelphia, Pa.), 2012, Volume: 5, Issue:4

    Topics: Aldehydes; alpha-Tocopherol; Animals; Anticarcinogenic Agents; Azoxymethane; Colonic Neoplasms; Cyclin D1; Dinoprost; Dinoprostone; gamma-Tocopherol; Immunohistochemistry; Male; Models, Chemical; Rats; Rats, Inbred F344; Tocopherols; Tyrosine

2012
Development and evaluation of tocopherol-rich argan oil-based nanoemulsions as vehicles possessing anticancer activity.
    Journal of biomedical nanotechnology, 2012, Volume: 8, Issue:6

    Topics: Animals; Antineoplastic Agents; Biocompatible Materials; Breast Neoplasms; Cell Line, Tumor; Colonic Neoplasms; Drug Screening Assays, Antitumor; Emulsions; Female; Inhibitory Concentration 50; Mice; Models, Chemical; Nanomedicine; Plant Oils; Polyethylene Glycols; Rats; Tocopherols; Vitamin E

2012
Vitamin E succinate inhibits colon cancer liver metastases.
    The Journal of surgical research, 2002, Volume: 106, Issue:2

    Topics: Animals; Apoptosis; Carcinoma; Cell Division; Colonic Neoplasms; Liver; Liver Neoplasms; Mice; Tocopherols; Tumor Cells, Cultured; Vitamin E

2002
Gamma (gamma) tocopherol upregulates peroxisome proliferator activated receptor (PPAR) gamma (gamma) expression in SW 480 human colon cancer cell lines.
    BMC cancer, 2003, Oct-01, Volume: 3

    Topics: Cell Line, Tumor; Colonic Neoplasms; Humans; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Tocopherols; Transcription Factors; Tumor Cells, Cultured; Up-Regulation

2003
Chemopreventive effect of dietary d-alpha-tocopheryl succinate supplementation on precancer colon aberrant crypt formation and vitamin E analogue levels in young and old rats.
    Nutrition and cancer, 2004, Volume: 49, Issue:1

    Topics: Aging; Animals; Antioxidants; Azoxymethane; Carcinogens; Colon; Colonic Neoplasms; Dietary Supplements; Female; Rats; Rats, Sprague-Dawley; Tissue Distribution; Tocopherols; Vitamin E

2004
Alpha-tocopheryl succinate sensitizes human colon cancer cells to exisulind-induced apoptosis.
    Apoptosis : an international journal on programmed cell death, 2007, Volume: 12, Issue:2

    Topics: Antineoplastic Agents; Apoptosis; Caspase Inhibitors; Cell Growth Processes; Colonic Neoplasms; Drug Synergism; Enzyme Activation; Enzyme Inhibitors; HCT116 Cells; Humans; JNK Mitogen-Activated Protein Kinases; Sulindac; Tocopherols; Vitamin E

2007
Induction of cancer cell apoptosis by alpha-tocopheryl succinate: molecular pathways and structural requirements.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2001, Volume: 15, Issue:2

    Topics: Animals; Antibodies, Monoclonal; Apoptosis; Caspase 3; Caspases; Colonic Neoplasms; Colorectal Neoplasms; Enzyme Inhibitors; fas Receptor; Genes, bcl-2; Humans; Isoenzymes; Jurkat Cells; Kinetics; Mice; Mice, Nude; Oligodeoxyribonucleotides, Antisense; Phosphoprotein Phosphatases; Protein Kinase C; Protein Kinase C-alpha; Protein Phosphatase 2; Tetradecanoylphorbol Acetate; Tocopherols; Transplantation, Heterologous; Tumor Cells, Cultured; Vitamin E

2001
Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:3

    Topics: alpha-Tocopherol; Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Caspases; Colonic Neoplasms; Colony-Forming Units Assay; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Drug Synergism; Humans; Membrane Glycoproteins; Mice; Myocardial Contraction; Myocardium; Neoplasm Invasiveness; TNF-Related Apoptosis-Inducing Ligand; Tocopherols; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53; Vitamin E; Xenograft Model Antitumor Assays

2002